Advertisement
Skip to Content

Fidelity Advisor® Biotechnology M FBTTX

Quantitative rating as of
  • NAV / 1-Day Return 23.15  /  1.67 %
  • Total Assets 1.8 Bil
  • Adj. Expense Ratio
    1.280%
  • Expense Ratio 1.280%
  • Distribution Fee Level Average
  • Share Class Type Front Load
  • Category Health
  • Investment Style Mid Growth
  • Min. Initial Investment 0
  • Status Open
  • TTM Yield 0.00
  • Turnover 43%

Morningstar’s Analysis FBTTX

Will FBTTX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Summary

|

A lowering of its Process Pillar rating is the primary driver of Fidelity Advisor® Biotechnology M's downgrade to a Morningstar Quantitative Rating of Neutral from Bronze. Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.

Unlock our full analysis with Morningstar Investor